1. Home
  2.  » 
  3. Cell Therapy
  4.  » 
  5. Cell Type Solutions
  6.  » Pluripotent & Other Cells

Pluripotent & Other Cells

Back to top

MESENCHYMAL CELLS (MSC)

Recently, efforts are underway to optimize modified hematopoietic stem cells (HSC) for therapeutic potential in emerging indications such as sickle cell disease. Catalent has made investments in full-scale capabilities from viral vector production to cell therapy manufacturing to support customer programs specialized in gene-edited HSCs. Our teams possess the scientific, process development and scale-up expertise customized for hematopoietic cells. Our fully-integrated teams across the cell and gene therapy network offer an accelerated transition from raw material to commercial-scale manufacturing.

Back to top

HEMATOPOIETIC CELLS (HSC)

Recently, efforts are underway to optimize modified hematopoietic stem cells (HSC) for therapeutic potential in emerging indications such as sickle cell disease. Catalent has made investments in full-scale capabilities from viral vector production to cell therapy manufacturing to support customer programs specialized in gene-edited HSCs. Our teams possess the scientific, process development and scale-up expertise customized for hematopoietic cells. Our fully-integrated teams across the cell and gene therapy network offer an accelerated transition from raw material to commercial-scale manufacturing.